We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sundial Growers Inc. (SNDL) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
In the latest trading session, Sundial Growers Inc. (SNDL - Free Report) closed at $0.62, marking a +1.93% move from the previous day. This change outpaced the S&P 500's 1.58% gain on the day. Meanwhile, the Dow gained 1.22%, and the Nasdaq, a tech-heavy index, added 0.46%.
Prior to today's trading, shares of the company had gained 8.16% over the past month. This has outpaced the Medical sector's loss of 4.03% and the S&P 500's loss of 5.54% in that time.
Sundial Growers Inc. will be looking to display strength as it nears its next earnings release.
Any recent changes to analyst estimates for Sundial Growers Inc. should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Sundial Growers Inc. currently has a Zacks Rank of #3 (Hold).
Digging into valuation, Sundial Growers Inc. currently has a Forward P/E ratio of 61. This valuation marks a premium compared to its industry's average Forward P/E of 16.02.
The Medical - Drugs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 155, which puts it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sundial Growers Inc. (SNDL) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Sundial Growers Inc. (SNDL - Free Report) closed at $0.62, marking a +1.93% move from the previous day. This change outpaced the S&P 500's 1.58% gain on the day. Meanwhile, the Dow gained 1.22%, and the Nasdaq, a tech-heavy index, added 0.46%.
Prior to today's trading, shares of the company had gained 8.16% over the past month. This has outpaced the Medical sector's loss of 4.03% and the S&P 500's loss of 5.54% in that time.
Sundial Growers Inc. will be looking to display strength as it nears its next earnings release.
Any recent changes to analyst estimates for Sundial Growers Inc. should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Sundial Growers Inc. currently has a Zacks Rank of #3 (Hold).
Digging into valuation, Sundial Growers Inc. currently has a Forward P/E ratio of 61. This valuation marks a premium compared to its industry's average Forward P/E of 16.02.
The Medical - Drugs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 155, which puts it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.